Study on intervention effect of Jieduquyuziyin prescription systemic lupus erythematosus by HPLC-Q-TOF/MS.
- Author:
Jin-Bo HU
1
;
Heng-Cun GU
1
;
Zhi-Shan DING
1
;
Li YAO
1
;
Yong-Sheng FAN
1
;
Xing-Hong DING
1
Author Information
1. Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Publication Type:Journal Article
- MeSH:
Amino Acids;
blood;
Animals;
Chromatography, High Pressure Liquid;
Drugs, Chinese Herbal;
administration & dosage;
chemistry;
Fatty Acids;
blood;
Female;
Humans;
Lupus Erythematosus, Systemic;
blood;
drug therapy;
Male;
Mass Spectrometry;
Mice;
Serum;
chemistry
- From:
China Journal of Chinese Materia Medica
2013;38(21):3747-3752
- CountryChina
- Language:Chinese
-
Abstract:
To establish a metabonomic method based on high performance liquid chromatography-quadrupole-time of flight mass spectrometry (HPLC-Q-TOF/MS), in order to study the changes in serum metabolites of systemic lupus erythematosus (SLE) mice after treatment of Jieduquyuziyin prescription, the pathogenesis of SLE and mechanism of drug action. The orthogonal partial least squares (OPLS) was applied for the pattern recognition of experimental data, finding a significant difference in the control group, the SLE model group, the Jieduquyuziyin prescription-treated group and the prednisone acetate-treated group. According to the OPLS load diagram, 12 differential metabolites, including traumatic acid, PAF, 12 (S)-HEPE, 15(S)-HETrE and Hepoxilin B3 were identified by using accurate mass combined with MS/MS data After treatment with Jieduquyuziyin prescription, the relative contents of PAF, 12 (S)-HETE were close to the level of the control group. According to the analysis on metabolic pathway, SLE could cause significant changes in unsaturated fatty acid and amino acid metabolism pathway, while Jieduquyuziyin prescription has a effect in regulating disorder of unsaturated fatty acid metabolism pathway.
